NovoCure
2,799
$60.389876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$60.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.31 (+0.52%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell NovoCure and other stocks, options, ETFs, and crypto commission-free!
About NVCR
NovoCure Limited Ordinary Shares, also called NovoCure, is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Read More Helier, Jersey.
Employees
782
Headquarters
St. Helier, Jersey
Founded
2000
Market Cap
6.06B
Price-Earnings Ratio
743.44
Dividend Yield
—
Average Volume
1.68M
High Today
$60.78
Low Today
$59.80
Open Price
$60.26
Volume
270.02K
52 Week High
$98.84
52 Week Low
$53.40
Collections
Analyst Ratings
57%
of 7 ratings
Buy
57%
Hold
29%
Sell
14%
NVCR Earnings
-$0.17
-$0.10
-$0.03
$0.04
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Jul 30, Pre-Market